Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01156974 · ClinicalTrials.gov registry record · Phase 2

Care Guides in the Primary Care Office (Phase II)

A Phase 2 study, sponsored by Allina Health System.

Completed
Registry status
Phase 2
Development phase
2,135
Enrollment target

NCT01156974: Completed Phase 2 study, sponsored by Allina Health System.

NCT01156974 is a Phase 2 study that has completed, run by Allina Health System. The registered enrollment target is 2,135 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1505% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01156974, a Phase 2 study, has completed, sponsored by Allina Health System.

COMPLETED
Registry status
Phase 2
Development phase
2,135 participants
Enrollment target

Study Summary

Trained lay persons ("care guides") working with chronic disease patients and their providers can help outpatients with diabetes, hypertension, and congestive heart failure achieve standard clinical care goals

Primary Outcome

Predetermined care goals as recommended by national authorities such as American Diabetes Association, American Heart Association, JNC-7.

Interventions

  • BEHAVIORAL education only
  • BEHAVIORAL education and care guide

Trial Details

FieldValue
Enrollment Target 2,135 participants
Start Date 2010-07
Est. Completion 2012-04
Phase Phase 2
Allina Health System

32 total trials

What the finished NCT01156974 record still lists

NCT01156974 is an interventional study that assigns participants to a tested intervention. Its 2,135 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1505% higher).

The record links to 0 conditions, and to 2 interventions - of which education only is the first listed.

NCT01156974 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01156974 about?

NCT01156974 is a clinical study titled "Care Guides in the Primary Care Office (Phase II)". Trained lay persons ("care guides") working with chronic disease patients and their providers can help outpatients with diabetes, hypertension, and congestive heart failure achieve standard clinical care goals

What is the current status of trial NCT01156974?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,135 participants. The study started on 2010-07. Estimated completion is 2012-04.

What interventions are being tested in trial NCT01156974?

The interventions under investigation include: education only (BEHAVIORAL), education and care guide (BEHAVIORAL).

Who is sponsoring clinical trial NCT01156974?

This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01156974's enrollment target sits among peer trials

2,135 8th of 2000 higher than 1,993 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05650658 · 2,136 participants · NA

    Left vs Left Randomized Clinical Trial

  • NCT03488693 · 2,140 participants · Phase 3

    Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

  • NCT07431281 · 2,130 participants · Phase 3

    Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • NCT06598475 · 2,142 participants · NA

    Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01156974, the US trial registry maintained by the National Library of Medicine. NCT01156974 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.